Junson Asset Management (Hong Kong) LTD Athenex, Inc. Transaction History

Junson Asset Management (Hong Kong) LTD

  • $0
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 19, 2021
SELL
$4.08 - $14.75 $287,640 - $1.04 Million
-70,500 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$11.06 - $14.01 $779,730 - $987,705
70,500 New
70,500 $780,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Junson Asset Management (Hong Kong) LTD Portfolio

Follow Junson Asset Management (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Junson Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Junson Asset Management (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email